Yarger Wealth Strategies LLC Has $103,000 Holdings in agilon health, inc. (NYSE:AGL)

Yarger Wealth Strategies LLC decreased its holdings in agilon health, inc. (NYSE:AGL) by 12.4% in the 4th quarter, HoldingsChannel reports. The firm owned 53,966 shares of the company’s stock after selling 7,655 shares during the quarter. Yarger Wealth Strategies LLC’s holdings in agilon health were worth $103,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently bought and sold shares of AGL. Oak Thistle LLC acquired a new position in shares of agilon health during the fourth quarter worth approximately $25,000. Point72 Asia Singapore Pte. Ltd. bought a new position in agilon health in the 3rd quarter worth approximately $28,000. Pines Wealth Management LLC acquired a new position in agilon health during the 4th quarter worth $51,000. City State Bank bought a new position in agilon health in the 3rd quarter valued at $52,000. Finally, Aigen Investment Management LP acquired a new stake in shares of agilon health in the 3rd quarter valued at $79,000.

agilon health Price Performance

Shares of AGL stock opened at $2.97 on Friday. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. agilon health, inc. has a 52 week low of $1.50 and a 52 week high of $7.73. The company’s 50 day moving average price is $2.07 and its two-hundred day moving average price is $3.67.

agilon health (NYSE:AGL) last issued its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.19). The company had revenue of $1.45 billion for the quarter, compared to the consensus estimate of $1.47 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. During the same period in the prior year, the company earned ($0.06) EPS. Equities research analysts forecast that agilon health, inc. will post -0.59 earnings per share for the current year.

Wall Street Analyst Weigh In

AGL has been the topic of several research reports. Barclays cut their price target on agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a research note on Monday, November 11th. TD Cowen reduced their target price on shares of agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a research note on Monday, November 11th. Citigroup upgraded shares of agilon health from a “sell” rating to a “neutral” rating and lifted their price target for the stock from $1.75 to $2.25 in a research report on Friday, January 10th. Royal Bank of Canada restated an “outperform” rating and issued a $3.00 price objective on shares of agilon health in a report on Tuesday, November 19th. Finally, Macquarie initiated coverage on shares of agilon health in a report on Monday, December 16th. They set a “neutral” rating and a $3.00 target price for the company. Two analysts have rated the stock with a sell rating, fourteen have given a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $4.03.

Insider Buying and Selling at agilon health

In other agilon health news, Director Karen Mcloughlin acquired 25,000 shares of the business’s stock in a transaction dated Friday, December 13th. The shares were acquired at an average price of $2.20 per share, with a total value of $55,000.00. Following the completion of the transaction, the director now directly owns 73,166 shares in the company, valued at $160,965.20. This trade represents a 51.90 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Diana Mckenzie bought 12,500 shares of the firm’s stock in a transaction that occurred on Monday, November 25th. The stock was acquired at an average cost of $2.28 per share, with a total value of $28,500.00. Following the transaction, the director now owns 51,319 shares of the company’s stock, valued at $117,007.32. This represents a 32.20 % increase in their position. The disclosure for this purchase can be found here. Insiders have bought 90,000 shares of company stock valued at $198,100 in the last 90 days. 3.20% of the stock is currently owned by company insiders.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.